NDRG2 controls COX-2/PGE₂-mediated breast cancer cell migration and invasion

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• N-myc downstream-regulated gene 2 (NDRG2) exhibits tumor suppressor functions and is often downregulated in breast cancers.
• NDRG2 may play a role in inhibiting the migration and invasion of malignant tumor cells.
• Cyclooxygenase-2 (COX-2) is implicated in promoting cancer cell motility.

Purpose of the Study:

• To investigate the inhibitory effects of NDRG2 overexpression on breast cancer cell migration.
• To elucidate the role of cyclooxygenase-2 (COX-2) in NDRG2-mediated inhibition of cell migration and invasion.
• To examine the impact of NDRG2 on nuclear transcription factor-κB (NF-κB) signaling pathway.

Main Methods:

• Overexpression of NDRG2 in MDA-MB-231 breast cancer cells.
• Knockdown of NDRG2 using siRNA in MCF7 breast cancer cells.
• Assessment of COX-2 mRNA, protein expression, transcriptional activity, and prostaglandin E2 (PGE2) production.
• Analysis of NF-κB signaling pathway activation.
• Evaluation of cell migration and invasion assays.

Main Results:

• NDRG2 overexpression inhibited COX-2 expression, PGE2 production, and NF-κB signaling in MDA-MB-231 cells.
• Inhibition of COX-2 by NDRG2 suppressed PMA-induced migration and invasion.
• NDRG2 knockdown in MCF7 cells increased COX-2 expression and enhanced PMA-induced migration and invasion.
• NDRG2 negatively regulates COX-2 expression through the NF-κB pathway.

Conclusions:

• NDRG2 suppresses breast cancer cell migration and invasion.
• NDRG2 exerts its inhibitory effects by down-regulating COX-2 expression via the NF-κB signaling pathway.
• These findings highlight NDRG2 as a potential therapeutic target for reducing breast cancer metastasis.